位置:成果数据库 > 期刊 > 期刊详情页
Traditional Chinese Medicine syndrome patterns and Qi-regulating, chest-relaxing and blood-activating therapy on cardiac syndrome X
  • ISSN号:1672-1349
  • 期刊名称:《中西医结合心脑血管病杂志》
  • 时间:0
  • 分类:S858.292[农业科学—临床兽医学;农业科学—兽医学;农业科学—畜牧兽医] TS255[轻工技术与工程—农产品加工及贮藏工程;轻工技术与工程—食品科学与工程]
  • 作者机构:[1]Department of Cardiovascular, the FirstTeaching Hospital of Tianjin University of Chinese Medicine,Tianjin 300193, China, [2]Department of Cardiovascular,Guang'anmen Hospital of China Academy of Chinese Medi-cal Sciences, Beijing 100053, China
  • 相关基金:Special Project of National Clinical Research Base of TCM (No. JDZX2012140), Innovation Team Develop- ment Plan of the Ministry of Education (No. IRT1276)
中文摘要:

目的将掌握症候群模式特征并且为心脏的症候群 X (CSX ) 探索繁体中文药(TCM ) 的有效治疗方法。TCM 症候群特征被掌握的方法和 TCM 干预节目被临床的调查为 CSX 病人的 TCM 症候群模式特征决定。然后,为 CSX 的 TCM 干预上的临床的功效研究通过使随机化的控制试用被执行。结果 CSX 是有胸疼痛和胸的主要表明的临床的症候群不通风,和 Qi 停滞,痰保留和血壅滞是 CSX 的基本症状。作为结果,调整 Qi,与一些西方的药综合的放松胸、激活血的治疗为治疗被采用。 调整Qi 的效果,放松胸、激活血的治疗罐头减少咽峡炎的频率和学位,改进症状并且行使病人的忍耐,禁止脉管的墙的煽动性的反应并且保护脉管的 endothelial 房间的功能,它独自比简单、常规的西方的药的好。好效果为 CSX 在中国、西方的药的集成被完成的结论。治疗是值钱的在临床的实践进一步被使用。在另一方面,长期的更多和有大样品的控制研究仍然是的 randomised 要求了进一步决定治疗的临床的功效和安全。

英文摘要:

OBJECTIVE: To master the syndrome patterns char- acteristics and explore the effective therapy meth- ods of Traditional Chinese Medicine (TCM) for cardi- ac syndrome X (CSX). METHODS: The TCM syndrome characteristics were mastered and the TCM intervention pro- grams were determined by clinical investigations for TCM syndrome patterns characteristics of CSX patients. Then, the clinical efficacy studies on TCM intervention for CSX were carried out through ran- domized controlled trials. RESULTS: CSX is a clinical syndrome with the main manifestations of chest pain and chest stuffiness, and Qi stagnation, phlegm retention and blood sta- sis are the basic symptoms of CSX. As a result, the Qi-regulating, chest-relaxing and blood-activatingtherapy integrated with some Western Medicines was adopted for treatment. The effect of Qi-regulat- ing, chest-relaxing and blood-activating therapy can reduce the frequency and degree of angina, im- prove the symptoms and exercise the tolerance of patients, inhibit the inflammatory response of vas- cular walls and protect the function of vascular en- dothelial cells, which is better than that of the sim- ple and conventional Western Medicine alone. CONCLUSION: A good effect was achieved in the integration of Chinese and Western Medicines for CSX. The therapy is worthy to be applied further in clinical practice. On the other hand, more long-term and randomised controlled studies with large samples are still required to further deter- mine the clinical efficacy and safety of the therapy.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中西医结合心脑血管病杂志》
  • 中国科技核心期刊
  • 主管单位:山西省卫生厅
  • 主办单位:中国中西医结合学会 山西医科大学第一医院
  • 主编:王斌全 吕吉元
  • 地址:太原市解放南路85号
  • 邮编:030001
  • 邮箱:zxyjhxnxgbzz@vip.163.com
  • 电话:0351-4639124
  • 国际标准刊号:ISSN:1672-1349
  • 国内统一刊号:ISSN:14-1312/R
  • 邮发代号:
  • 获奖情况:
  • 国内外数据库收录:
  • 中国中国科技核心期刊
  • 被引量:33537